Aysel Sunnetcioglu, Mehmet Berkoz, Metin Yildirim, Gulhan Bora, Serap Yalin
JPMA. The Journal of the Pakistan Medical Association 2020 DecThe aim of this study was to assess the influence of plasminogen activator inhibitor-1 (PAI-1) 4G/5G or tissue plasminogen activator (tPA) I/D polymorphisms in chronic obstructive pulmonary disease (COPD) cases in a sample of Turkish population. PAI-1 4G/5G and tPA Alu-repeat I/D genetic polymorphisms in 153 COPD subjects and 160 controls were investigated using PCR-RFLP and PCR methods, respectively. 4G allele frequency was 0.62 and 0.39 for COPD and control groups, respectively. 4G allele had an estimated 2.56- fold [95% CI = 1.85-3.53] increased risk of COPD. tPA I allele frequency was 0.55 and 0.50, for COPD and control groups, respectively. I allele had an estimated 1.19-fold [95% CI = 0.87-1.62] increased risk of COPD. PAI-1 4G/4G and 4G/5G genotypes seemed to play a key role in the pathophysiology of COPD in Turkish individuals.
Aysel Sunnetcioglu, Mehmet Berkoz, Metin Yildirim, Gulhan Bora, Serap Yalin. PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population. JPMA. The Journal of the Pakistan Medical Association. 2020 Dec;70(12(B)):2310-2315
PMID: 33475534
View Full Text